What question did this study set out to answer?

March 15, 2026American Journal of Clinical Oncology0 citations

Efficacy and Safety of Pulsed Low-Dose Rate Radiotherapy in Re-Irradiation of Recurrent Solid Tumors

XZXinyan ZhangXuzhou Medical College ZLZifang LiuSun Yat-sen University HJHuacong JinXuzhou Medical College

Puntos clave

This research examines the efficacy and safety of pulsed low-dose rate radiotherapy in recurrent solid tumors.
Evaluated pulsed low-dose rate radiotherapy (PLDR) for re-irradiation of recurrent solid tumors.
Analyzed patient characteristics such as IDH1 mutation status, recurrence location, and re-irradiation interval.
PLDR re-irradiation shows favorable efficacy and safety in recurrent solid tumors.
Patients with IDH1 mutation and nontemporal lobe recurrence benefit more from PLDR.
Longer re-irradiation intervals (>24 months) are associated with greater treatment advantages.

Resumen

PLDR re-irradiation demonstrates favorable efficacy and safety in recurrent solid tumors. For recurrent glioma, patients with IDH1 mutation, nontemporal lobe recurrence, and a re-irradiation interval >24 months appear to derive greater benefit from PLDR radiotherapy.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo